Prizes5.2 - A PRIZE SYSTEM AS A PARTIAL SOLUTION TO THE...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
1 A P RIZE S YSTEM AS A P ARTIAL S OLUTION TO THE H EALTH C RISIS IN THE D EVELOPING W ORLD William W. Fisher ** *** I NTRODUCTION ................................................................................................................................ 1 I. P RIZES : A G ENERAL F RAMEWORK .............................................................................................. 3 A. Opportunities. ....................................................................................................................... 3 B. Hazards. .............................................................................................................................. 12 II. O PTIMAL D ESIGN ...................................................................................................................... 21 A. Defining the Contest . ......................................................................................................... 21 B. The Nature and Size of the Prize. ....................................................................................... 28 C. The Relationship between the Prize System and the Patent System. ................................. 57 D. Managing Redundancy . ..................................................................................................... 66 E. Sequential Innovation. ........................................................................................................ 72 F. Incrementally Modified Drug Produts. .............................................................................. 78 G. Geographic Scope . ............................................................................................................. 82 C ONCLUSION .................................................................................................................................. 84 I NTRODUCTION Each year, roughly nine million people in the developing world die from infectious diseases. 1 Millions more endure suffering caused by the same diseases. Many of those deaths and much of that pain could be avoided by modifying the combination of laws and government programs that provide incentives for the development and distribution of drugs. In a recent paper, we argued that such modifications are morally imperative, despite the fact that they would increase the already substantial extent to which the cost of developing new drugs is borne by the residents of the developed world, ** Wilmer Hale Professor of Intellectual Property Law, Harvard Law School. *** S.J.D. (Doctoral) Candidate and Petrie-Flom Fellow, Harvard Law School. The authors thank Herrick Fisher, Amy Kapczynski, Roni Mann, Pam Samuelson, and the participants in workshops at Fordham Law School and University of California, Berkeley, Law School for their generous comments. Talha Syed thanks the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics for generous financial support. 1
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 01/13/2012 for the course LAW 41415A taught by Professor Williamfisher during the Spring '10 term at Harvard.

Page1 / 89

Prizes5.2 - A PRIZE SYSTEM AS A PARTIAL SOLUTION TO THE...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online